SIRPLUX Trademark

Trademark Overview

On Friday, January 21, 2022, a trademark application was filed for SIRPLUX with the United States Patent and Trademark Office. The USPTO has given the SIRPLUX trademark a serial number of 97232367. The federal status of this trademark filing is SU - REGISTRATION REVIEW COMPLETE as of Friday, November 7, 2025. This trademark is owned by Advanced Nanotherapies Inc.. The SIRPLUX trademark is filed in the Medical Instrument Products category with the following description:

Medical devices, namely, drug-coated balloons, balloon catheters, drug delivery catheters, drug-eluting balloon catheters, and medical stents; Pharmaceutical products and preparations for the treatment of cardiovascular and endovascular disease sold as integral components of medical balloon catheters; Drug delivery agents in the form of nanoparticles that facilitate the delivery of pharmaceutical preparations sold as integral components of medical balloon catheters
sirplux

General Information

Serial Number97232367
Word MarkSIRPLUX
Filing DateFriday, January 21, 2022
Status819 - SU - REGISTRATION REVIEW COMPLETE
Status DateFriday, November 7, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 6, 2022

Trademark Statements

Pseudo MarkSURPLUS
Goods and ServicesMedical devices, namely, drug-coated balloons, balloon catheters, drug delivery catheters, drug-eluting balloon catheters, and medical stents; Pharmaceutical products and preparations for the treatment of cardiovascular and endovascular disease sold as integral components of medical balloon catheters; Drug delivery agents in the form of nanoparticles that facilitate the delivery of pharmaceutical preparations sold as integral components of medical balloon catheters

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateWednesday, January 26, 2022
Primary Code010
First Use Anywhere DateTuesday, January 10, 2023
First Use In Commerce DateTuesday, January 10, 2023

Trademark Owner History

Party NameAdvanced Nanotherapies Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCleveland, OH 44106
Party NameAdvanced Nanotherapies Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCleveland, OH 44106

Trademark Events

Event DateEvent Description
Tuesday, January 25, 2022NEW APPLICATION ENTERED
Wednesday, January 26, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, October 31, 2022ASSIGNED TO EXAMINER
Tuesday, November 1, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 16, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 6, 2022PUBLISHED FOR OPPOSITION
Tuesday, December 6, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 31, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, July 31, 2023SOU TEAS EXTENSION RECEIVED
Monday, July 31, 2023SOU EXTENSION 1 FILED
Monday, July 31, 2023SOU EXTENSION 1 GRANTED
Wednesday, August 2, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 7, 2023ASSIGNED TO EXAMINER
Tuesday, January 30, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, January 30, 2024SOU EXTENSION 2 FILED
Tuesday, January 30, 2024SOU EXTENSION 2 GRANTED
Thursday, February 1, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 24, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, July 24, 2024SOU EXTENSION 3 FILED
Wednesday, July 24, 2024SOU EXTENSION 3 GRANTED
Wednesday, July 24, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 30, 2025SOU TEAS EXTENSION RECEIVED
Thursday, January 30, 2025SOU EXTENSION 4 FILED
Thursday, January 30, 2025SOU EXTENSION 4 GRANTED
Friday, January 31, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 31, 2025TEAS STATEMENT OF USE RECEIVED
Monday, July 7, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, March 31, 2025USE AMENDMENT FILED
Monday, July 7, 2025STATEMENT OF USE PROCESSING COMPLETE
Thursday, October 9, 2025SU - NON-FINAL ACTION - WRITTEN
Thursday, October 9, 2025NON-FINAL ACTION E-MAILED
Thursday, October 9, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, November 4, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, November 7, 2025ASSIGNED TO LIE
Friday, November 7, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, November 7, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, November 7, 2025ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, November 7, 2025NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Related Keywords

sirplux catheters drug medical balloon delivery pharmaceutical preparations sold components integral